Your immune system protects you from disease, but with autoimmune disease, the system attacks healthy cells resulting in chronic inflammation. If not properly treated, and autoimmune disease can lead to lost productivity, disability and even death. The top 24 chronic inflammatory diseases impact 23.5 million people in the United States and results in $127 billion a year in healthcare spend.
Crossbridge helps physicians select a treatment option that is evidence-based with submission to the payer of prescription so that patients can begin treatment without delay. The Crossbridge platform provides advanced patient care by aligning the priorities of patients, physicians and payers. It is a win-win for providers and payers.
CrossBridge is an evidence-based medical library that is comprehensive, independent and non-biased. It includes evidence-based treatment regimens, including clinical outcome, levels of medical evidence and support. It is a transformative solution with proven treatment plans and helps patients receive the highest quality evidence-based treatments available.
CrossBridge helps physicians select a treatment option that is evidence-based with submission to the payer at the time of prescription so that patients can begin treatment without delay. It aligns the priorities of providers and payers and streamline administrative burden. It streamlines reduces variability in clinical care, and results in cost efficiencies to benefit all participants in the autoimmune treatment process.
We have entered the age of value-based care with its incentives improving outcomes. The CrossBridge platform help coordinate care among teams, delivers personalized treatment with the goals of reducing cost and ineffective care. It delivers formulary and cost transparency at the clinical setting to inform physicians and patients for shared decisions about treatments.